Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)

Clinical trial NCT00217178 · UNKNOWN

Trial details

NCT number: NCT00217178
Sponsor: Hamilton Health Sciences Corporation
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atherosclerosis Cardiovascular Disease

Start date: 2000-01-01
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.